Total Payments
$4,083
2021 Payments
$937.78
Companies
26
Transactions
259
Medicare Patients
5,034
Medicare Billing
$308,421
Payment Breakdown by Category
Food & Beverage$4,008 (98.2%)
Education$74.68 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,008 | 253 | 98.2% |
| Education | $74.68 | 6 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,345 | 91 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $770.52 | 37 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $502.94 | 33 | $0 (2021) |
| Grifols USA, LLC | $343.78 | 49 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $245.44 | 10 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $131.95 | 5 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $107.00 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $106.74 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $97.32 | 5 | $0 (2021) |
| Genentech USA, Inc. | $69.65 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $937.78 | 44 | GlaxoSmithKline, LLC. ($390.71) |
| 2020 | $604.40 | 40 | AstraZeneca Pharmaceuticals LP ($172.02) |
| 2019 | $1,098 | 58 | GlaxoSmithKline, LLC. ($421.32) |
| 2018 | $603.61 | 39 | GlaxoSmithKline, LLC. ($180.65) |
| 2017 | $839.70 | 78 | Grifols USA, LLC ($200.77) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Pulmonology | ||||||
| 12/06/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 10/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/12/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: VACCINE | ||||||
| 10/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Pulmonology | ||||||
| 09/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 09/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Respiratory | ||||||
| 07/29/2021 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: PAH | ||||||
| 07/27/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Respiratory | ||||||
| 06/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Respiratory | ||||||
| 06/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 06/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $106.53 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 29 | 2,211 | 2,761 | $350,010 | $130,354 |
| 2020 | 32 | 2,823 | 5,274 | $441,566 | $178,067 |
Total Patients
5,034
Total Services
8,035
Medicare Billing
$308,421
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 366 | 542 | $114,665 | $50,204 | 43.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 441 | 581 | $42,704 | $12,860 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 203 | $31,380 | $12,212 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 134 | $20,100 | $7,340 | 36.5% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2021 | 76 | 76 | $22,800 | $7,085 | 31.1% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 72 | 72 | $12,750 | $6,729 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 42 | 42 | $12,600 | $5,521 | 43.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 43 | 49 | $11,010 | $4,729 | 42.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 66 | 67 | $5,025 | $4,347 | 86.5% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 238 | 254 | $11,340 | $3,902 | 34.4% |
| 71250 | Diagnostic ct scan of chest | Office | 2021 | 50 | 55 | $20,056 | $3,053 | 15.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,100 | $2,142 | 42.0% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 19 | 23 | $1,700 | $1,449 | 85.2% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 60 | 87 | $2,305 | $1,342 | 58.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 77 | 78 | $2,106 | $1,291 | 61.3% |
| 76641 | Ultrasound of one breast, complete | Office | 2021 | 12 | 13 | $4,150 | $789.60 | 19.0% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 15 | 15 | $2,135 | $727.46 | 34.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 36 | 38 | $2,936 | $638.40 | 21.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 17 | 17 | $2,083 | $554.43 | 26.6% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 13 | 13 | $650.00 | $504.53 | 77.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 41 | 47 | $3,361 | $496.32 | 14.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 36 | 36 | $3,600 | $482.04 | 13.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 17 | 17 | $850.00 | $436.87 | 51.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 48 | 56 | $2,800 | $435.12 | 15.5% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 28 | 28 | $2,940 | $252.98 | 8.6% |
About Dr. Gilbert Witte, M.D
Dr. Gilbert Witte, M.D is a Pulmonary Disease healthcare provider based in Olean, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598764730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Witte, M.D has received a total of $4,083 in payments from pharmaceutical and medical device companies, with $937.78 received in 2021. These payments were reported across 259 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,008).
As a Medicare-enrolled provider, Witte has provided services to 5,034 Medicare beneficiaries, totaling 8,035 services with total Medicare billing of $308,421. Data is available for 2 years (2020–2021), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Olean, NY
- Active Since 07/19/2005
- Last Updated 02/24/2009
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1598764730
Products in Payments
- TRELEGY ELLIPTA (Drug) $738.09
- NUCALA (Biological) $320.14
- SYMBICORT (Drug) $280.01
- Prolastin-C (Biological) $214.84
- STIOLTO RESPIMAT (Drug) $195.70
- ANORO (Drug) $157.46
- PNEUMOVAX 23 (Biological) $133.86
- Prolastin-C Liquid (Biological) $128.94
- IMFINZI (Drug) $125.00
- ELIQUIS (Drug) $106.74
- BEVESPI AEROSPHERE (Drug) $100.34
- LONHALA MAGNAIR (Drug) $97.75
- DUPIXENT (Biological) $97.32
- OFEV (Drug) $91.52
- FASENRA (Drug) $83.31
- STIOLTO (Drug) $79.33
- BREO (Drug) $77.82
- BREZTRI (Drug) $77.43
- SPIRIVA RESPIMAT (Drug) $73.37
- Esbriet (Biological) $53.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.